Moderna Inc. buy BMO Capital Markets
Start price
12.01.26
/
50%
€29.02
Target price
12.01.27
-
Performance (%)
311.65%
Price
10:52
€119.44
Summary
This prediction is currently active. With a performance of 311.65% the BUY prediction by BMO_Capital_Markets is a big success. This prediction currently runs until 12.01.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | 106.702% | 106.702% |
| iShares Core DAX® | -1.586% | 5.028% |
| iShares Nasdaq 100 | -4.148% | -0.125% |
| iShares Nikkei 225® | -6.302% | 0.528% |
| iShares S&P 500 | -3.225% | 0.470% |
Comments by BMO_Capital_Markets for this prediction
In the thread Moderna Inc. diskutieren
Moderna (NASDAQ:MRNA) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to a "buy" rating.
Ratings data for MRNA provided by MarketBeat

